These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 20922692)

  • 1. [Renal involvement in monoclonal gammopathy and multiple myeloma].
    De Sanctis LB; Sestigiani E; Sgarlato V; Fabbrizio B; Santoro A
    G Ital Nefrol; 2010; 27 Suppl 50():S19-33. PubMed ID: 20922692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical problems in kidney disorders associated with myeloma and other paraproteinemias].
    Merta M; Spicka I; Rysavá R; Zabka J; Tesar V; Zima T; Honsová E; Stejskalová A; Vorsilková M; Walterová J
    Sb Lek; 1996; 97(4):469-77. PubMed ID: 9424712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ultrastructural basis of renal pathology in monoclonal gammopathies.
    Santostefano M; Zanchelli F; Zaccaria A; Poletti G; Fusaroli M
    J Nephrol; 2005; 18(6):659-75. PubMed ID: 16358223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New aspects on the pathogenesis of renal disorders related to monoclonal gammopathies.
    Kapoulas S; Raptis V; Papaioannou M
    Nephrol Ther; 2015 Jun; 11(3):135-43. PubMed ID: 25861714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Scope of Kidney Affection in Monoclonal Gammopathies at All Levels of Clinical Significance.
    Mehtat Ünlü Ş; Özsan H; Sarıoğlu S
    Turk J Haematol; 2017 Dec; 34(4):282-288. PubMed ID: 28832010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Kidney damage in multiple myeloma and other monoclonal gammopathies].
    Adam Z; Pour L; Krejcí M; Stĕpánková S; Svobodová I; Veselý K; Hájek R
    Vnitr Lek; 2008 Sep; 54(9):847-61. PubMed ID: 18924346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney diseases associated with monoclonal immunoglobulin M-secreting B-cell lymphoproliferative disorders: a case series of 35 patients.
    Chauvet S; Bridoux F; Ecotière L; Javaugue V; Sirac C; Arnulf B; Thierry A; Quellard N; Milin S; Bender S; Goujon JM; Jaccard A; Fermand JP; Touchard G
    Am J Kidney Dis; 2015 Nov; 66(5):756-67. PubMed ID: 25987261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular lesions in monoclonal gammopathies and mixed essential cryoglobulinemias IgG-IgM.
    Verroust P; Mery JP; Morel-Maroger L; Clauvel JP; Richet G; Bouteiller AM; Fumagalli N
    Adv Nephrol Necker Hosp; 1971; 1():161-94. PubMed ID: 4377644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The kidney in dysproteinemia].
    Spanti D; Marcantoni C; Di Landro D
    G Ital Nefrol; 2005; 22 Suppl 33():S39-45. PubMed ID: 16419005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal involvement in monoclonal gammopathies].
    Spicka I; Merta M; Cieslar P; Stejskalová A
    Cas Lek Cesk; 1996 Jun; 135(12):374-7. PubMed ID: 8706074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
    Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
    Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination of thrombotic microangiopathy and nodular sclerosis in light chain deposition disease.
    Kanjanabuch T; Bunruang R; Srisawat N; Lewsuwan S; Kittikovit V; Eiam-Ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S248-52. PubMed ID: 17044479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nephropathies in the course of plasma cell disorders].
    Hanicki Z
    Przegl Lek; 1995; 52(3):97-9. PubMed ID: 7644685
    [No Abstract]   [Full Text] [Related]  

  • 14. Spectrum of manifestations of monoclonal gammopathy-associated renal lesions.
    Sethi S; Fervenza FC; Rajkumar SV
    Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):127-37. PubMed ID: 26735145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: a single center experience.
    Stratta P; Gravellone L; Cena T; Rossi D; Gaidano G; Fenoglio R; Lazzarich E; Quaglia M; Airoldi A; Bozzola C; Monga G; Valente G; Canavese C; Magnani C
    Crit Rev Oncol Hematol; 2011 Jul; 79(1):31-42. PubMed ID: 20570173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of systemic light-chain deposition disease and amyloidosis: a report of three patients with renal involvement.
    Jacquot C; Saint-Andre JP; Touchard G; Nochy D; D'Auzac de Lamartinie C; Oriol R; Druet P; Bariety J
    Clin Nephrol; 1985 Aug; 24(2):93-8. PubMed ID: 3930115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bridging the Divide: An Onco-Nephrologic Approach to the Monoclonal Gammopathies of Renal Significance.
    Hogan JJ; Weiss BM
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1681-1691. PubMed ID: 27416775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Classification and therapeutic management of monoclonal gammopathies of renal significance].
    Javaugue V; Bouteau I; Sirac C; Quellard N; Diolez J; Colombo A; Desport E; Ecotière L; Goujon JM; Fermand JP; Touchard G; Jaccard A; Bridoux F
    Rev Med Interne; 2018 Mar; 39(3):161-170. PubMed ID: 28457684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple myeloma--presenting as acute kidney injury.
    Prakash J; Niwas SS; Parekh A; Vohra R; Wani IA; Sharma N; Usha
    J Assoc Physicians India; 2009 Jan; 57():23-6. PubMed ID: 19753754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal disease in multiple myeloma].
    Hiromura K; Nojima Y
    Nihon Rinsho; 2007 Dec; 65(12):2229-34. PubMed ID: 18069265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.